Missing/wrong data?
Log in to edit
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
scientific article published on November 16, 2015
Author/s
author: Isabelle Ray-Coquard, Sandro Pignata, Ignace Vergote, Mariusz Bidziński, Giovanni Scambia, Felix Hilpert, Nicoletta Colombo, Gunnar B. Kristensen, Mansoor Raza Mirza
Work details
Publication date
November 13, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.